雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

New Development in Osteoporosis Treatment. Intermittent long-term administration of intravenous bisphosphonates for treatment of osteoporosis. Miyakoshi Naohisa 1 1Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Japan. pp.93-99
Published Date 2013/12/28
DOI https://doi.org/10.20837/4201401093
  • Abstract
  • Look Inside
  • Reference

 Bisphosphonates(BPs)are prescribed most frequently in an oral formulation. However, they have very limited bioavailability, and less than 1% of BPs administered orally are absorbed. In addition, poor adherence to oral BPs has been shown to be associated with suboptimal fracture reduction and prevention. Therefore, intravenous BP regimens have been developed to address this issue. In Japan, intermittent intravenous administration of alendronate and ibandronate on a monthly basis is currently available, and intravenous zoledronate on a yearly basis is expected to be available in the near future. Data have shown that intravenous BPs are noninferior to oral BPs in preventing osteoporotic fractures. Furthermore, intravenous BP administration is particularly advantageous in patients who do not tolerate or adhere to oral BPs, including those with gastrointestinal pathology, polypharmacy, or the inability to remain upright.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有